Trial Profile
A Randomised, Parallel Group, Double Blind, Placebo Controlled, Add on Clinical Trial to Investigate Whether the Lithium Mimetic, Ebselen, Can Reduce Symptoms of Hypomania and Mania in Bipolar Patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ebselen (Primary)
- Indications Bipolar disorders
- Focus Proof of concept; Therapeutic Use
- 04 May 2020 According to a Sound Pharmaceuticals media release, The Stanley Medical Research Institute (SMRI), a leading funder of clinical trials involving psychiatric disease, provided support for this University of Oxford clinical trial.
- 04 May 2020 Results published in a Sound Pharmaceuticals media release.
- 18 Sep 2019 According to a Sound Pharmaceuticals media release, top-line data expected later this year.